Target Organ Damage
Showing 1 - 25 of >10,000
Hypertension Trial in London (Beetroot juice)
Recruiting
- Hypertension
- Beetroot juice
-
London, United KingdomQueen Mary University of London
Jan 10, 2023
Central Blood Pressure and Pulse Wave Velocity With Target Organ
Completed
- Diabetes
- Cardiovascular Disease
-
Salamanca, SpainPrimary care Research unit. La Alamedilla health centre
Feb 20, 2020
Endothelial Glycocalyx Damage in Brain Death Organ Donors
Recruiting
- Brain Damage Due to Hypoxia
- +2 more
- Endothelial glycocalyx damage assessment
-
Hradec Kralove, CzechiaUniversity Hospital Hradec Kralove
Nov 5, 2022
White-coat Hypertension in Childhood - Effects on Blood Pressure
Completed
- White Coat Hypertension
- (no location specified)
Jun 16, 2023
Blood Pressure and Subclinical Organ Damage
Completed
- Diabetes Mellitus
-
Salamanca, SpainLuis Garcia Ortiz
Feb 20, 2020
Digital-health Based Intervention on Subclinical Organ Damage
Not yet recruiting
- Cardiovascular Diseases
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital, Tongji University School of Me
Jun 23, 2022
Vascular Tone Control After Bariatric Surgery
Completed
- Systemic Vascular Resistance
-
Barcelona, SpainHospital del Mar_Nefrology
Mar 4, 2020
Masked Hypertension Trial in Shanghai (Allisartan Isoproxil, Placebo)
Active, not recruiting
- Masked Hypertension
- Allisartan Isoproxil
- Placebo
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 27, 2021
Hypertension Trial in Beijing (Spironolactone, Indapamide, Amlodipine)
Unknown status
- Hypertension
- Spironolactone
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Dec 1, 2019
IL17 in Systemic Lupus Erythematosus Patients: Association With
Not yet recruiting
- Systemic Lupus Erythematosus
- Serum level of IL-17
-
Sohag, EgyptSohag University Hospital
Sep 12, 2021
Sleep Apnea, Chronic Kidney Diseases Trial in São Paulo (CPAP)
Recruiting
- Sleep Apnea
- Chronic Kidney Diseases
- CPAP
-
São Paulo, BrazilFernanda Trani Ferreira
May 3, 2023
Cumulative Blood Pressure Load and Left Ventricular Mass
Recruiting
- Arterial Hypertension
- 24-hour ambulatory blood pressure monitoring (ABPM)
- Three-dimensional transthoracic echocardiography
-
Guayaquil, Guayas, EcuadorInstituto Ecuatoriano del Corazón
Jul 16, 2022
Dementia, Chronic Disease, Tumor Metastasis Trial (Jumpstart Guide)
Not yet recruiting
- Dementia
- +16 more
- Jumpstart Guide
- (no location specified)
Oct 24, 2022
DNA Damage in Critically Ill COVID-19 Patients
Recruiting
- Covid19
- +2 more
- COMET ASSAY
-
Hradec Králové, Třebeš, CzechiaUniversity Hospital Hradec Kralove
Feb 25, 2021
Menopause on Development of Heart Failure and Organ Damage of
Completed
- Hypertension
- Menopause
- AMH
-
Lodz, PolandHeart Failure Unit, Department of Cardiology and Congenital Malf
Mar 29, 2021
Exercise, Arterial Modulation and Nutrition in Youth South
Active, not recruiting
- Hypertension
- +2 more
-
Potchefstroom, North West, South AfricaHypertension in Africa Research Team (HART), North-West Universi
Apr 12, 2022
Deeply Phenotype Major Organs in Sickle Cell Disease After
Enrolling by invitation
- Mortality in Sickle Cell
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 13, 2022
Assess Demographic, Pharmacologic, Biomarker, Clinical Features
Recruiting
- Systemic Lupus Erythematosus
- Participant completed survey
- Medical chart review
-
Dubai, United Arab EmiratesGSK Investigational Site
Apr 21, 2022
Congenital Heart Disease, Congenital Heart Defect, Congenital Heart Malformations Trial in Nashville (Nitric Oxide (NO) 20 part
Enrolling by invitation
- Congenital Heart Disease
- +2 more
- Nitric Oxide (NO) 20 part per million (ppm)
- Standard of care cardiopulmonary bypass
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 25, 2022
Sickle Cell Disease Trial in Créteil (Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease)
Not yet recruiting
- Sickle Cell Disease
- Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease
-
Créteil, FranceHospital Henri Mondor
Jan 5, 2022
Sepsis, Severe Sepsis, End Organ Damage Trial in Boston (vitamin D3, Placebo)
Withdrawn
- Sepsis
- +3 more
- vitamin D3
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Apr 30, 2021
Hypertension, Hyperaldosteronaemia Trial (Spironolactone, Finerenone, Blank control)
Not yet recruiting
- Hypertension
- Hyperaldosteronaemia
- Spironolactone
- +2 more
- (no location specified)
Jan 15, 2023
Systemic Lupus Erythematosus Trial in Germany (Treat-to-target as a new treatment concept)
Not yet recruiting
- Systemic Lupus Erythematosus
- Treat-to-target as a new treatment concept
-
Freiburg, Baden Wurttemberg, Germany
- +13 more
Jan 25, 2023
Hypertension, Obstructive Sleep Apnea Trial in Shanghai (Continuous positive airway pressure)
Recruiting
- Hypertension
- Obstructive Sleep Apnea
- Continuous positive airway pressure
-
Shanghai, Shanghai, ChinaShanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
Feb 9, 2023